(Q34604474)

3 August 2017

1 reference

title

Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit (English)

1 reference

cutaneous lupus erythematosus

3 August 2017

0 references

1 reference

A Wozniacka

1

1 reference

3 August 2017

A Carter

series ordinal

2

1 reference

3 August 2017

D P McCauliffe

series ordinal

3

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

11

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

71-81

1 reference

Antimalarial therapy: a panacea for mild lupus?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Quinoline antimalarials: mechanisms of action and resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and Hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Chloroquine-quinacrine association in resistant cutaneous lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Cutaneous cryptococcosis; presentation of a case and a review of previously reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Acrodermatitis chronica atrophicans; report of a case treated with chloroquine phosphate (aralen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Anti-malarials in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Annular elastolytic giant cell granuloma: sparing of a burn scar and successful treatment with chloroquine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Pharmacologic actions of 4-aminoquinoline compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Studies on the mechanism of drug-binding to melanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Studies on lysosome stabilization by antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The effects of lysosomotropic amines on protein degradation, migration of nonhistone proteins to the nucleus, and cathepsin D in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Autoimmune disease. a problem of defective apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Cigarette smoking enhances the elimination of quinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Mannose 6-, fructose 1-, and fructose 6-phosphates inhibit human natural cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Inhibition of SK cell activity in frogs by certain drugs and sugars

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Action of lysosomotropic amines on spontaneous and interferon enhanced NK and CTL cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Arachidonic acid metabolism in guinea pig skin: effects of chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Influence of niridazole and chloroquine on arterial and myometrial prostacyclin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

A study of the mechanisms of chloroquine retinopathy. I. Chloroquine effect on lipid peroxidation of retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Inhibition of lipid peroxidation in muscle homogenates by phospholipase A2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Effects of chloroquine on lysosomal enzymes, NADPH-induced lipid peroxidation, and antioxidant enzymes of rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Lysosomotropic agents ameliorate macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: a role for lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Chloroquine self-treatment and clinical outcome of cerebral malaria in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Immunosuppressive potential of antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Lupus erythematosus profundus with partial C4 deficiency responding to thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The pathogenesis of rheumatoid arthritis: from molecules to the whole patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Regulation of apoptosis in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Action of chloroquine phosphate in rheumatoid arthritis. 1. Immunosuppressive effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Effect of chloroquine on erythematous and carcinogenic response to ultraviolet light. Demonstrated in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Sensitivity to UV light during treatment with chloroquine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Intradermal administration of chloroquine for discoid lupus erythematosus and lichen sclerosus et atrophicus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Antioxidant action of antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

On the inhibitory effect of chloroquine on blood platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Inhibition of very-low-density lipoprotein secretion by chloroquine, verapamil and monensin takes place in the Golgi complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Inhibition of hepatic cholesterol biosynthesis by chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

In Vivo Chloroquine-induced Inhibition of Insulin Degradation in a Diabetic Patient with Severe Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

The effects of low temperature and chloroquine on 125I-insulin degradation by the perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Biochemical characterization of ADP-ribose polymer metabolism in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

Subacute cutaneous lupus erythematosus-immunogenetic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU147RR

10.1191/0961203302LU147RR

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference